Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...

Ageing reversal may be closer than we think – scientists have begun human trials to test anti-ageing methods.

The field of partial reprogramming is transitioning from successful mouse studies to its first human clinical trials. At the heart of this experiment lies the discovery of Yamanaka ...

Life Biosciences, a Boston longevity biotech co-founded by Harvard genetics professor David Sinclair, has locked down an $80 ...

HexemBio has launched with a seed round led by Draper Associates to advance a blood stem cell rejuvenation therapy backed by Robert Langer.

HexemBio emerges with a breakthrough blood stem cell rejuvenation technology led by Draper Associates and an advisory ...

A first-of-its-kind study led by the Medical University of South Carolina raises questions about the value of fish oil ...

Khaberni - The human intestine harbors over 100 trillion microorganisms, performing functions far beyond digestion, extending ...

Portland scientists at Oregon Health & Science University say they have figured out why pancreatic tumors so often brush off ...

FF Global President, Jerry Wang and Chris Chen, Co-CEO of FF AI-Robotics at FF, participated in panel discussions where they ...

Scientists at the Salk Institute for Biological Studies and Sanford Burnham Prebys explore genetic factors in separate papers ...

Faraday Future Intelligent Electric Inc. (Nasdaq: FFAI) ("Faraday Future," "FF," or the "Company"), a California-based global ...